Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 26, 2022
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
[ Wed, Oct 26th 2022
] - WOPRAI
David Westenberg Maintained (ADPT) at Hold with Decreased Target to $7.5 on, Oct 26th, 2022
David Westenberg of Piper Sandler, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Hold with Decreased Target from $12 to $7.5 on, Oct 26th, 2022.
David has made no other calls on ADPT in the last 4 months.
There is 1 other peer that has a rating on ADPT. Out of the 1 peers that are also analyzing ADPT, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Dan Leonard of "Credit Suisse" Initiated at Sell and Held Target at $8 on, Thursday, August 25th, 2022
